Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

More COX-2 inhibitors from Searle

Oct. 4, 1996

Dana Farber discloses unique antiherpetic therapy

Oct. 4, 1996

Antiherpesvirus agents from Eisai

Oct. 4, 1996

Pharmacia & Upjohn continues investigation of oxazolidinones

Oct. 4, 1996

Takeda discloses cephem antibacterial compounds

Oct. 4, 1996

Merck & Co. reports 5-HT1Dalpha receptor agonists

Oct. 4, 1996

Janssen describes vasoconstrictors for migraine Rx

Oct. 4, 1996

Tachykinin antagonists disclosed by Sanofi

Oct. 4, 1996

Aldose reductase inhibitors from Dainippon

Sep. 27, 1996

Prokinetic agents from Nisshin Flour Milling

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...